拓新藥業（301089.SZ）股東結構 - 機構持倉、大股東與內部人士｜長橋證券

股東類型

個人與內幕人士54.20%
公眾及其他45.41%
機構投資者0.25%
私人企業0.14%

主要股東

主要股東最新
股東
Xining YangChairman of the Board	27.29%	3,453.26 萬	0.06%	+7.70 萬	11/08/2026
Shenglin XianFormer Director	13.00%	1,644.74 萬	0.67%	-85.00 萬	07/09/2026
Yuying CaiVP & Director	4.19%	530.78 萬	0.00%	+0	31/12/2025
Hao LiuFormer Chairman of the Supervisory Board	3.64%	460.04 萬	0.00%	+0	31/03/2025
Guirong QuDirector	3.15%	398.05 萬	<0.01%	+6,000.00	04/09/2026
Chunhong DongFormer Supervisor	1.60%	202.50 萬	0.00%	+0	31/12/2025
Xiuqiang WangDeputy General Manager	1.31%	165.24 萬	0.00%	+0	31/12/2025
Xinxiang Yiwosi Trading Co., Ltd.	0.14%	17.79 萬	0.00%	+0	06/06/2025
Gfund Management Co., Ltd.	0.13%	15.98 萬	0.00%	+0	31/12/2025
Wanjia Asset Management Co., Ltd.	0.06%	6.99 萬	0.00%	+0	31/12/2025
Golden Trust SinoPac Fund Management Co., Ltd.	0.05%	6.50 萬	0.00%	+0	31/12/2025
Yanxing Shao	0.02%	3.12 萬	--	+3.12 萬	23/07/2026
Zhong Ou Fund Management Co., Ltd	0.01%	1.73 萬	0.00%	+0	30/06/2025
Huijuan JiaoChief Financial Officer	<0.01%	9,000.00	0.00%	+0	31/12/2024
Guanjun Ma	<0.01%	1,000.00	--	+1,000.00	03/09/2026
Penghua Fund Management Co., Ltd.	<0.01%	440.00	0.00%	+0	31/12/2025
Lion Fund Management Co. Ltd.	<0.01%	220.00	0.00%	+0	31/12/2025
New China Fund Management Co., Ltd.	<0.01%	20.00	0.00%	+0	31/12/2025